{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:33:48Z","timestamp":1761129228915},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,28]],"date-time":"2015-03-28T00:00:00Z","timestamp":1427500800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-0894-z","type":"journal-article","created":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T20:35:02Z","timestamp":1427488502000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people"],"prefix":"10.1186","volume":"15","author":[{"given":"Hye-Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seoyeon","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhyung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwangsook","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Joon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geun-Ryang","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Seok","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Yeon","family":"Hyeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,28]]},"reference":[{"key":"894_CR1","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/rmv.663","volume":"20","author":"C Savolainen-Kopra","year":"2010","unstructured":"Savolainen-Kopra C, Blomqvist S. Mechanisms of genetic variation in polioviruses. Rev Med Virol. 2010;20:358\u201371.","journal-title":"Rev Med Virol"},{"key":"894_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev.ge.27.120193.002033","volume":"27","author":"E Wimmer","year":"1993","unstructured":"Wimmer E, Hellen CU, Cao X. Genetics of poliovirus. Ann Rev Genet. 1993;27:353\u2013436.","journal-title":"Ann Rev Genet"},{"key":"894_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.122.3159.105","volume":"122","author":"D Bodian","year":"1955","unstructured":"Bodian D. Emerging concept of poliomyelitis infection. Science. 1955;122:105\u20138.","journal-title":"Science"},{"key":"894_CR4","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1126\/science.123.3209.1151","volume":"123","author":"AB Sabin","year":"1956","unstructured":"Sabin AB. Pathogenesis of poliomyelitis; reappraisal in the light of new data. Science. 1956;123:1151\u20137.","journal-title":"Science"},{"key":"894_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-3527(08)00001-8","volume":"71","author":"N Nathanson","year":"2008","unstructured":"Nathanson N. The pathogenesis of poliomyelitis: what we don\u2019t know. Adv Virus Res. 2008;71:1\u201350.","journal-title":"Adv Virus Res"},{"key":"894_CR6","first-page":"107","volume":"53","author":"Centers for Disease Control and Prevention (CDC)","year":"2004","unstructured":"Centers for Disease Control and Prevention (CDC). Global polio eradication initiative strategic plan, 2004. MMWR Morb Mortal Wkly Rep. 2004;53:107\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"894_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","volume":"59","author":"OM Kew","year":"2005","unstructured":"Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol. 2005;59:587\u2013635.","journal-title":"Annu Rev Microbiol"},{"key":"894_CR8","first-page":"222","volume":"50","author":"Centers for Disease Control and Prevention (CDC)","year":"2001","unstructured":"Centers for Disease Control and Prevention (CDC). Apparent global interruption of wild poliovirus type 2 transmission. MMWR Morb Mortal Wkly Rep. 2001;50:222\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"894_CR9","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMoa1303368","volume":"369","author":"HM Luo","year":"2013","unstructured":"Luo HM, Zhang Y, Wang XQ, Yu WZ, Wen N, Yan DM, et al. Identification and control of a poliomyelitis outbreak in Xinjiang, China. N Engl J Med. 2013;369:1981\u201390.","journal-title":"N Engl J Med"},{"key":"894_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1017\/S0950268803001663","volume":"132","author":"YM Jee","year":"2004","unstructured":"Jee YM, Cheon DS, Kim KS, Lee SH, Yoon JD, Lee SW, et al. A seroprevalence study of poliovirus antibody among primary schoolchildren in Korea. Epidemiol Infect. 2004;132:351\u20135.","journal-title":"Epidemiol Infect"},{"key":"894_CR11","doi-asserted-by":"publisher","first-page":"7041","DOI":"10.1016\/j.vaccine.2007.07.060","volume":"25","author":"Y Tano","year":"2007","unstructured":"Tano Y, Shimizu H, Martin J, Nishimura Y, Simizu B, Miyamura T. Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains. Vaccine. 2007;25:7041\u20136.","journal-title":"Vaccine"},{"key":"894_CR12","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/jmv.23763","volume":"86","author":"HJ Kim","year":"2013","unstructured":"Kim HJ, Kang BH, Hwang SY, Lee SW, Cheon DS, Kim KS, et al. Clinical and enterovirus findings associated with acute flaccid paralysis in the Republic of Korea during the recent decade. J Med Virol. 2013;86:1584\u20139.","journal-title":"J Med Virol"},{"key":"894_CR13","first-page":"87","volume-title":"Polio laboratory manual","author":"World Health Organization","year":"2004","unstructured":"World Health Organization. Polio laboratory manual. 4th ed. Geneva, Switzerland: WHO; 2004. p. 87\u2013100.","edition":"4"},{"key":"894_CR14","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.2807\/esm.12.06.00717-en","volume":"12","author":"M Pires de Miranda","year":"2007","unstructured":"Pires de Miranda M, Carmo Gomes M, Rebelo de Andrade H. Seroprevalence of antibodies to poliovirus in individuals living in Portugal, 2002. Euro Surveill. 2007;12:E7\u20138.","journal-title":"Euro Surveill"},{"key":"894_CR15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S0934-8840(11)80515-3","volume":"280","author":"B Weber","year":"1994","unstructured":"Weber B, Rabenau H, Cinatl J, Maass G, Doerr HW. Quantitative detection of neutralizing antibodies against polioviruses and non-polio enteroviruses (NPEV) using an automated microneutralization assay: a seroepidemiologic survey. Zentralbl Bakteriol. 1994;280:540\u20139.","journal-title":"Zentralbl Bakteriol"},{"key":"894_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2334-12-24","volume":"12","author":"C Reinheimer","year":"2012","unstructured":"Reinheimer C, Friedrichs I, Rabenau HF, Doerr HW. Deficiency of immunity to poliovirus type 3: a lurking danger? BMC Infect Dis. 2012;12:24.","journal-title":"BMC Infect Dis"},{"key":"894_CR17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/bmj.305.6845.79","volume":"305","author":"R Joce","year":"1992","unstructured":"Joce R, Wood D, Brown D, Begg N. Paralytic poliomyelitis in England and Wales, 1985\u201391. BMJ. 1992;305:79\u201382.","journal-title":"BMJ"},{"key":"894_CR18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1096\/fasebj.8.9.8005394","volume":"8","author":"FC Robbins","year":"1994","unstructured":"Robbins FC. Poliomyelitis eradication: a continuing story. FASEB J. 1994;8:665\u20136.","journal-title":"FASEB J"},{"key":"894_CR19","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1016\/j.vaccine.2009.02.042","volume":"27","author":"MC P\u00edrez","year":"2009","unstructured":"P\u00edrez MC, Olivera I, Diabarboure H, Montano A, Bara\u00f1ano R, Bad\u00eda F, et al. Seroprevalence of anti-polio antibodies in a population 7 months to 39 years of age in Uruguay: Implications for future polio vaccination strategies. Vaccine. 2009;27:2689\u201394.","journal-title":"Vaccine"},{"key":"894_CR20","first-page":"425","volume":"81","author":"World Health Organization (WHO)","year":"2006","unstructured":"World Health Organization (WHO). Outbreak of type-1 wild poliovirus in adults, Namibia, 2006. WklyEpidemiol Rec. 2006;81:425\u201330.","journal-title":"WklyEpidemiol Rec"},{"key":"894_CR21","first-page":"1393","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC). Outbreaks following wild poliovirus importations\u2014Europe, Africa, and Asia, January 2009\u2013September 2010. MMWR Morb Mortal Wkly Rep. 2010;59:1393\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"894_CR22","first-page":"353","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","unstructured":"Centers for Disease Control and Prevention (CDC). Progress toward interruption of wild poliovirus transmission\u2014worldwide, January 2011\u2013March 2012. MMWR Morb Mortal Wkly Rep. 2012;61:353\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"894_CR23","first-page":"95","volume":"76","author":"World Health Organization (WHO)","year":"2001","unstructured":"World Health Organization (WHO). Transmission of wild poliovirus type 2: apparent global interruption. Wkly Epidemiol Rec. 2001;76:95\u20137.","journal-title":"Wkly Epidemiol Rec"},{"key":"894_CR24","first-page":"157","volume":"76","author":"P Affanni","year":"2005","unstructured":"Affanni P, Veronesi L, Rizziero S, Bizzoco S, Bracchi MT, Tanzi ML. Status of immunity against poliomyelitis: a study among European and extra-European young immigrants living in Parma. Acta Biomed. 2005;76:157\u201363.","journal-title":"Acta Biomed"},{"key":"894_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2334-2-2","volume":"2","author":"S Diedrich","year":"2002","unstructured":"Diedrich S, Claus H, Schreier E. Immunity status against poliomyelitis in Germany: determination of cut-off values in international units. BMC Infect Dis. 2002;2:2.","journal-title":"BMC Infect Dis"},{"key":"894_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S1473-3099(11)70190-6","volume":"12","author":"CF Est\u00edvariz","year":"2012","unstructured":"Est\u00edvariz CF, Jafari H, Sutter RW, John TJ, Jain V, Agarwal A, et al. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6\u20139 months in Moradabad, India: a community-based, randomised controlled trial. Lancet Infect Dis. 2012;12:128\u201335.","journal-title":"Lancet Infect Dis"},{"key":"894_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/vim.2006.0071","volume":"20","author":"SV Nates","year":"2007","unstructured":"Nates SV, Martinez LC, Barril PA, Ferreyra LJ, Giordano MO, Masachessi G, et al. Long-lasting poliovirus-neutralizing antibodies among Argentinean population immunized with four or five oral polio vaccine doses 1 month to 19 years previously. Viral Immunol. 2007;20:3\u201310.","journal-title":"Viral Immunol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-0894-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0894-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0894-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0894-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T09:54:51Z","timestamp":1630576491000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-0894-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,28]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["894"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-0894-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,28]]},"assertion":[{"value":"1 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"164"}}